CoChat

Discovering Biomarkers in Peritoneal Metastasis of Gastric Cancer by Metabolomics

Open access
Pan, Guoqiang, Ma, Yuehan, Suo, Jian, Li, Wei, Zhang, Yang, Qin, Shanshan, Jiao, Yan, Zhang, Shaopeng, Li, Shuang, Kong, Yuan, Du, Yu, Gao, Shengnan, Wang, Daguang · 2020 · OncoTargets and Therapy

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Background and Objective: Metabolomics has recently been applied in the field of oncology. In this study, we aimed to use metabolomics to explore biomarkers in peritoneal metastasis of gastric cancer. Methods: Peritoneal lavage fluid (PLF) of 65 gastric cancer patients and related clinical data were collected from the First Hospital of Jilin University. The metabolic components were identified by liquid chromatography-mass spectrometry (LC-MS). Total ion current (TIC) spectra, principal component analysis (PCA), and the Student’s t -test were used to identify differential metabolites in PLF. A support vector machine (SVM) was used to screen the differential metabolites in PLF with a weight of 100%. Cluster analysis was used to evaluate the similarity between samples. Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic ability of the metabolites. Univariate and multivariate logistic regression analyses were used to identify potential risk factors for peritoneal metastasis of gastric cancer. Results: We found the differential levels of PLF metabolites by LC-MS, TIC spectra, PCA and the t -test. Cluster analysis showed the co-occurrence of metabolites in the peritoneal metastasis group (p< 0.05). ROC analysis showed the diagnostic ability of metabolites (p< 0.05). Univariate and multivariate logistic regression analyses showed the potential independent risk factors for peritoneal metastasis in gastric cancer patients (p< 0.05). Conclusion: Through the statistical analysis of metabolomics, we found that TG (54:2), G3P, α-aminobutyric acid, α-CEHC, dodecanol, glutamyl alanine, 3-methylalanine, sulfite, CL (63:4), PE-NMe (40:5), TG (53:4), retinol, 3-hydroxysterol, tetradecanoic acid, MG (21:0/0:0/0:0), tridecanoic acid, myristate glycine and octacosanoic acid may be biomarkers for peritoneal metastasis of gastric cancer. Keywords: gastric cancer, metabolomics, peritoneal metastasis, diagnosis

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ott.s245663

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 TIC spectra of the different groups. TIC analysis of groups A and B (A and B), groups C and D (C and D), and groups E and F (E and F).
Figure 1 TIC spectra of the different groups. TIC analysis of groups A and B (A and B), groups C and D (C and D), and groups E and F (E and F).CC BY-NC · PubMed Central
Figure 2 PCA of the different groups. PCA of groups A and B (A and B), groups C and D (C and D), and groups E and F (E and F).
Figure 2 PCA of the different groups. PCA of groups A and B (A and B), groups C and D (C and D), and groups E and F (E and F).CC BY-NC · PubMed Central
Figure 3 Cluster analysis of the different groups. Cluster analysis of groups A and B (A), groups C and D (B), and groups E and F (C).
Figure 3 Cluster analysis of the different groups. Cluster analysis of groups A and B (A), groups C and D (B), and groups E and F (C).CC BY-NC · PubMed Central
Figure 4 ROC curve analysis of metabolites in the different groups. ROC curve analysis of differential metabolites between groups A and B (A), groups C and D (B), and groups E and F (C).
Figure 4 ROC curve analysis of metabolites in the different groups. ROC curve analysis of differential metabolites between groups A and B (A), groups C and D (B), and groups E and F (C).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Research works printed but not linked: 2

  1. Carioli, 2019, Int J Cancer
  2. Oppermann, 2019, Cell Prolif, e12702

Cited by

See all 45

Metadata

Authors
Pan, G., Ma, Y., Suo, J., Li, W., Zhang, Y., Qin, S., Jiao, Y., Zhang, S., Li, S., Kong, Y., Du, Y., Gao, S., & Wang, D.
Affiliations
  • First Hospital of Jilin University (CN)
  • Affiliated Hospital of Qingdao University (CN)
Corresponding author
Wang, Daguang
Venue
OncoTargets and Therapy
Published
2020-07
Volume
Volume 13
Pages
7199-7211
ISSN
1178-6930 (ISSN-L)
OpenAlex
W3045423502
Cited by
45
References
52
Citations by year
2026: 4 · 2025: 3 · 2024: 21 · 2023: 6 · 2022: 8 · 2021: 3
FWCI
1.38
Type
journal article
Language
en
Open access
Locations
  • OncoTargets and Therapy (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
Keywords
gastric cancer, peritoneal carcinomatosis, biomarkers, peritoneal lavage fluid, differential metabolites, diagnostic biomarkers, risk factors, lipid metabolism, phospholipids, sphingolipids, amino acids, sulfite

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discovering Biomarkers in Peritoneal Metastasis of Gastric Cancer by Metabolomics. https://app.cochat.ai/papers/10.2147/ott.s245663
The paper
Pan, G., Ma, Y., Suo, J., Li, W., Zhang, Y., Qin, S., Jiao, Y., Zhang, S., Li, S., Kong, Y., Du, Y., Gao, S., & Wang, D. (2020). Discovering Biomarkers in Peritoneal Metastasis of Gastric Cancer by Metabolomics. OncoTargets and Therapy. https://doi.org/10.2147/ott.s245663

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.